Covalon Technologies (OTCMKTS:CVALF) Trading Down 3.1%

Covalon Technologies Ltd. (OTCMKTS:CVALFGet Free Report) was down 3.1% during trading on Friday . The stock traded as low as $0.87 and last traded at $0.87. Approximately 7,269 shares traded hands during mid-day trading, an increase of 111% from the average daily volume of 3,453 shares. The stock had previously closed at $0.90.

Covalon Technologies Price Performance

The stock has a 50-day moving average of $0.85 and a 200 day moving average of $0.99.

Covalon Technologies Company Profile

(Get Free Report)

Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has three proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; and medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device.

Recommended Stories

Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.